Search results
New weight loss drugs are on the way — and the health benefits are even more promising
The Independent via Yahoo News· 1 hour agoHowever, some weight loss drugs including Ozempic have been criticized for causing muscle loss and...
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
Yahoo Finance· 33 minutes agoThe leaders in the business of weight-loss drugs, Novo Nordisk and Eli Lilly, are fighting on a...
Ex-White House doctor Ronny Jackson calls on Biden to take drug test before Trump debate
Fox News· 1 hour agoFIRST ON FOX: Rep. Ronny Jackson, R-Texas, the White House physician-turned-House lawmaker, is...
Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing
Reuters via Yahoo Finance· 11 minutes agoObesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection...
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
Bloomberg· 2 hours agoThe new class of weight-loss drugs are being tested as cure-alls for everything from knee...
ResMed Stock Dives. Blame Eli Lilly’s Zepbound Trials for Sleep Apnea.
Barrons.com· 1 hour agoStrong results from Eli Lilly’s obesity medicine in a sleep apnea trial could upset the sleep apnea...
Maddow Blog | Ahead of debate, Trump tries to delegitimize a possible defeat
MSNBC via Yahoo News· 2 hours agoLast month, Republican Rep. Greg Murphy of North Carolina went so far as to tell Fox Business that...
Drug and drink driver who killed passenger jailed
BBC via AOL· 2 hours agoPolice said David Farrow had taken drugs and was drinking before the fatal collision [Lincolnshire Police] A man who drove a car into parked vehicles,...
Former White House Doctor Demands Biden Gets Tested for ‘Performance-Enhancing Drugs’ Before and...
IJR· 6 hours agoRep. Ronny Jackson (R-Texas), a former White House physician, is calling for President Joe Biden to...
Alnylam Soars on Positive Heart-Drug Data
The Wall Street Journal· 39 minutes agoAlnylam Pharmaceuticals’ stock jumped over 35% after the company’s closely watched heart drug performed well in a late-stage clinical trial. The drug,...
